Literature DB >> 22816787

Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.

Waleed Ghanima, Soo Y Lee, Sarah Barsam, Allison Miller, Per M Sandset, James B Bussel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22816787     DOI： 10.1111/j.1365-2141.2012.09227.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.

Authors:  Jose Ramon Gonzalez-Porras; Jose Maria Bastida
Journal:  Ther Adv Drug Saf       Date:  2018-04-19

2.  Ischemic stroke associated with immune thrombocytopenia.

Authors:  HongMei Zhao; YaJun Lian; HaiFeng Zhang; NanChang Xie; YanLun Gao; ZhongYue Wang; Yi Zhang
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

3.  Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience.

Authors:  Füsun Özdemirkıran; Bahriye Payzın; H Demet Kiper; Sibel Kabukçu; Gülsüm Akgün Çağlıyan; Selda Kahraman; Ömür Gökmen Sevindik; Cengiz Ceylan; Gürhan Kadıköylü; Fahri Şahin; Ali Keskin; Öykü Arslan; Mehmet Ali Özcan; Gülnur Kabukçu; Gülsüm Görgün; Zahit Bolaman; Filiz Büyükkeçeci; Oktay Bilgir; İnci Alacacıoğlu; Filiz Vural; Murat Tombuloğlu; Zafer Gökgöz; Güray Saydam
Journal:  Turk J Haematol       Date:  2015-04-27       Impact factor: 1.831
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.